文章摘要
sST2 MMP-2 MMP-9与急性心肌梗死并发心力衰竭患者预后的相关性
Correlation between sST2, MMP-2 and MMP-9 and prognosis in patients with acute myocardial infarction complicated with heart failure
投稿时间:2019-11-07  
DOI:10.3969/j.issn.1000-0399.2020.07.005
中文关键词: 可溶性生长刺激表达基因2蛋白  基质金属蛋白酶-2  基质金属蛋白酶-9  急性心肌梗死  心力衰竭
英文关键词: Soluble growth stimulation expressed gene 2  Matrix metalloproteinase-2  Matrix metalloproteinase-9  Acute myocardial infarction  Heart failure
基金项目:海南省卫生计生行业科研项目(项目编号:19A200072)
作者单位
王芳 572000 三亚 海南省第三人民医院心血管内科 
韦迎娜 572000 三亚 海南省第三人民医院心血管内科 
尹涛源 572000 三亚 海南省第三人民医院心血管内科 
摘要点击次数: 1452
全文下载次数: 0
中文摘要:
      目的 探讨血清可溶性生长刺激表达基因2蛋白(sST2)和基质金属蛋白酶(MMP)-2、MMP-9水平与急性心肌梗死(AMI)并发心力衰竭(HF)患者预后的相关性。方法 选取2017年5月至2018年5月在海南省第三人民医院住院的AMI患者149例,记录患者入院后相关数据,检测入院时血清sST2、MMP-2、MMP-9水平,根据住院期间是否并发HF分为HF组(54例)和无HF组(95例),出院后随访12个月,根据是否出现恶性HF、心源性死亡等将AMI并发HF患者分为预后不良组(n=16)和预后良好组(n=38),比较HF组和无HF组以及预后不良组和预后良好组血清sST2、MMP-2、MMP-9水平,并采用受试者工作特征(ROC)曲线分析sST2、MMP-2、MMP-9对AMI并发HF患者预后的预测价值。结果 HF组血清sST2、MMP-2、MMP-9水平均高于无HF组,差异有统计学意义(P<0.05);HF组不良事件发生率为29.63%(16/54),预后不良组血清sST2、MMP-2、MMP-9水平均高于预后良好组,差异有统计学意义(P<0.05);sST2、MMP-2、MMP-9预测AMI并发HF患者预后的曲线下面积(AUC)分别为0.888、0.938、0.715。结论 AMI并发HF患者血清sST2、MMP-2、MMP-9明显增高,高水平血清sST2、MMP-2、MMP-9可能提示患者预后不良,sST2、MMP-2、MMP-9对患者预后有较好的预测价值。
英文摘要:
      Objective To explore the correlation between levels of serum soluble growth stimulation expressed gene 2 (sST2), matrix metalloproteinase (MMP)-2 and MMP-9 and prognosis in patients with acute myocardial infarction (AMI) complicated with heart failure (HF). Methods A total of 149 patients with AMI who were hospitalized in the Third People’s Hospital of Hainan Province from May 2017 to May 2018 were selected. The related data of patients after admission were recorded. The serum levels of sST2, MMP-2 and MMP-9 were measured at admission. According to whether HF was concurrent during hospitalization, the patients were divided into HF group (n=54) and non-HF group (n=95). At 12 months follow-up after discharge, the patients with AMI and HF were divided into poor prognosis group (n=16) and good prognosis group (n=38) according to whether there was malignant heart failure or cardiogenic death. The levels of serum sST2, MMP-2 and MMP-9 were compared between HF group and non-HF group and between poor prognosis group and good prognosis group. The receiver operating characteristic (ROC) curve was used to analyze the predictive value of sST2, MMP-2 and MMP-9 in the prognosis of patients with AMI complicated with HF. Results The levels of serum sST2, MMP-2 and MMP-9 in HF group were higher than those in non-HF group (P<0.05). The incidence rate of adverse events was 29.63% (16/54) in HF group, and the levels of serum sST2, MMP-2 and MMP-9 in patients with poor prognosis were higher than those in patients with good prognosis (P<0.05). Multivariate logistic regression analysis found that sST2, MMP-2 and MMP-9 were independent risk factors for the prognosis of patients with AMI complicated with HF (P<0.05). The values of area under the curve (AUC) of sST2, MMP-2 and MMP-9 in predicting the prognosis of AMI patients with HF were 0.888, 0.938 and 0.715 respectively. Conclusions The serum levels of sST2, MMP-2 and MMP-9 in patients with AMI and HF significantly increased, and high levels of serum sST2, MMP-2 and MMP-9 may indicate a poor prognosis, and sST2, MMP-2 and MMP-9 have a good predictive value in the prognosis of patients.
查看全文   查看/发表评论  下载PDF阅读器
关闭